Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  V.TLT.WT | TLTFF

Healthcare Medical Devices
Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Theralase Technologies Inc.
Bullboard Posts
User Avatar Image
(0)
•••
Comment by macman1519on Jan 25, 2018 5:21pm
57 Views
Post# 27435969

RE:RE:RE:RE:RE:Sanofi to Acquire Bioverativ for $11.6 Billion​

RE:RE:RE:RE:RE:Sanofi to Acquire Bioverativ for $11.6 Billion​Smallie, very nice subtle manipulating, yes ur for jv, yes u think our science is enough, yes a jv is being worked on behind closed doors!!! That would suit the white knight just Perfectly!!! But the best deal by far is a bidding war, not a deal worked behind closed doors, and as Vestor, suggests, May have been agreed upon months ago???????  Shareholders lose with white night. The frustration, uncertainty, sp collapse, is the manipulators working you over, so that when white knight is announced, we are all thankful, even though our azzes don't feel great!!! Life is a play, and this one is a doozy. Believe our results, our science, NOT THE MANIPULATORS DESTRUCTION OF OUR SP, AND THEIR ATTEMPT TO WEAKEN YOUR BELIEF IN THIS COMPANY SO YOU WILL TAKE LESS EVEN THOUGH PHARMA WILL GIVE YOU FAR MORE!!! BUT BBBBENNY AND THE CRICKETS AND THEIR MASTER DONT DISCUSS FINANCING, PHARMA OR WHAT IS REALLY BEST FOR US!! NOPE 
, THE CONFERENCES, THE VIDEO, THE FUTURE WILL BE GREAT!!! DONT worry, be happy, gazillions soon, just fewer than you might think. 




[quote=Smallcap84]It would make perfect sense to seek a JV unless what we have so far is not compelling enough to attract one,which I don't believe is the case.I suspect a JV is being discussed behind the scenes....[/quote]

Bullboard Posts
Dealroom for high-potential pre-IPO opportunities